NewAmsterdam Pharma (NAMS) Shares Issued (2023 - 2026)

NewAmsterdam Pharma has disclosed Shares Issued across 4 years of filings, most recently posting $10.4 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $10.4 million, up 5590.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.7 million (up 2527.33% YoY), and the FY2025 annual result was $29.5 million, up 1566.74% from the prior year.
• Shares Issued came in at $10.4 million for Q1 2026 at NewAmsterdam Pharma, down from $12.5 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $16.8 million in Q3 2025 to a low of -$12.9 million in Q3 2024.
• The 4-year median for Shares Issued is $2.4 million (2023), against an average of $3.9 million.
• Across the five-year window, Shares Issued slumped 99.99% in 2025 and soared 5590.71% in 2026, its largest moves.
• NewAmsterdam Pharma's Shares Issued stood at $8.3 million in 2023, then slumped by 84.76% to $1.3 million in 2024, then jumped by 884.57% to $12.5 million in 2025, then declined by 16.71% to $10.4 million in 2026.
• The last three Shares Issued figures came in at $10.4 million (Q1 2026), $12.5 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.